These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Ben Bouallègue F; Mariano-Goulart D; Payoux P; Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967 [TBL] [Abstract][Full Text] [Related]
14. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C; Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339 [TBL] [Abstract][Full Text] [Related]
15. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Apostolova LG; Hwang KS; Andrawis JP; Green AE; Babakchanian S; Morra JH; Cummings JL; Toga AW; Trojanowski JQ; Shaw LM; Jack CR; Petersen RC; Aisen PS; Jagust WJ; Koeppe RA; Mathis CA; Weiner MW; Thompson PM; Neurobiol Aging; 2010 Aug; 31(8):1284-303. PubMed ID: 20538372 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM; AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236 [TBL] [Abstract][Full Text] [Related]
18. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Shaw LM; Vanderstichele H; Knapik-Czajka M; Figurski M; Coart E; Blennow K; Soares H; Simon AJ; Lewczuk P; Dean RA; Siemers E; Potter W; Lee VM; Trojanowski JQ; Acta Neuropathol; 2011 May; 121(5):597-609. PubMed ID: 21311900 [TBL] [Abstract][Full Text] [Related]
19. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW; Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758 [TBL] [Abstract][Full Text] [Related]
20. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]